1. Advances in Interventional Neuroradiology 2005
- Author
-
David M. Pelz, Pedro Lylyk, Michael Söderman, Makoto Negoro, and Tommy B. Andersson
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Neurosurgery ,Carotid endarterectomy ,Credentialing ,law.invention ,Arteriovenous Malformations ,Randomized controlled trial ,law ,medicine ,Humans ,Stroke ,Interventional neuroradiology ,Endarterectomy ,Advanced and Specialized Nursing ,business.industry ,General surgery ,Angioplasty ,Stent ,Atherosclerosis ,medicine.disease ,Aneurysm ,Surgery ,Treatment Outcome ,Neuroradiography ,Stents ,Neurology (clinical) ,Carotid stenting ,Cardiology and Cardiovascular Medicine ,business - Abstract
In the wake of the SAPPHIRE trial1 and subsequent approval of carotid stenting (CAS) devices by the Food and Drug Administration (FDA) in the United States, CAS is poised to explode in the frequency of its application in North America. Although the results of the Carotid Revascularization Stenting versus Endarterectomy Trial (CREST), the largest randomized controlled trial comparing carotid endarterectomy to CAS, are years away, many practitioners in multiple disciplines have already entered the competition for patients and remuneration. Despite the absence of evidence to support CAS over carotid endarterectomy2,3 and the need to continue recruiting patients to CREST,4 cardiologists, vascular surgeons, neurologists, neurosurgeons, general interventional and neurointerventional radiologists are all vying to treat carotid stenoses, many of which are
- Published
- 2006